Two Cases of Psychosis and Mania Bring Up Questions About Abruptly Stopping GLP-1 Medication
Can stopping a GLP-1 medication affect mental health? A new study looks into the question after two men developed psychiatric conditions after coming off tirzepatide.
Two men developed psychiatric conditions after abruptly stopping tirzepatide, a GLP-1 medication. In August 2025, a 61-year-old man with a history of depression stopped taking tirzepatide due to nausea. Over the following month, his depression worsened, leading to confusion, suspicion, hearing and seeing things others didn't, and experiencing Cotard delusion.
In October, another 52-year-old man with a history of anxiety stopped tirzepatide after losing 100 pounds in six months. He also used cannabis frequently. Both men reported dramatic changes in mood and behavior shortly after stopping tirzepatide. The first man's hallucinations and delusions cleared, but he was later readmitted with depression and catatonia.
The second man was diagnosed with a manic episode and transferred to a psychiatric facility. Tests showed a low vitamin B12 level, which may be relevant to these cases. While the FDA's review of GLP-1 drugs found no increased risk of depression, anxiety, or psychosis, these two cases raise questions about the period after treatment ends.
The authors recommend that any discontinuation of GLP-1 medications should be closely monitored by a doctor, especially for those with a history of depression and anxiety.
Written by urgent.news from Discover Magazine's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.